Mackenzie Financial Corp Has $6.03 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mackenzie Financial Corp lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 77,952 shares of the company’s stock after selling 2,037 shares during the quarter. Mackenzie Financial Corp’s holdings in GE HealthCare Technologies were worth $6,027,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Waldron Private Wealth LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $214,000. Strs Ohio increased its position in shares of GE HealthCare Technologies by 14.6% in the fourth quarter. Strs Ohio now owns 159,174 shares of the company’s stock worth $12,307,000 after purchasing an additional 20,333 shares during the period. Vontobel Holding Ltd. bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth $4,794,000. Capital Advisors Inc. OK bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth $759,000. Finally, Louisiana State Employees Retirement System bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth $4,631,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $84.49 on Friday. The stock has a market cap of $38.56 billion, a P/E ratio of 27.98, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The stock’s 50-day moving average is $88.74 and its 200-day moving average is $77.89. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 earnings per share. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Mizuho raised their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price target for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Citigroup raised their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. HSBC began coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Finally, Evercore ISI lifted their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.